大類學(xué)科： 不限 醫(yī)學(xué) 生物 物理 化學(xué) 農(nóng)林科學(xué) 數(shù)學(xué) 地學(xué)天文 地學(xué) 環(huán)境科學(xué)與生態(tài)學(xué) 綜合性期刊 管理科學(xué) 社會科學(xué) 查看全部熱門領(lǐng)域
投稿咨詢
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.
Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.
《Cancer Immunology Research》是一本由AMER ASSOC CANCER RESEARCH出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2013年，刊期12 issues/year，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 1區(qū)，小類學(xué)科：免疫學(xué) 2區(qū)；腫瘤學(xué) 2區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q1。該刊發(fā)文范圍涵蓋免疫學(xué)等領(lǐng)域，旨在及時、準(zhǔn)確、全面地報道國內(nèi)外免疫學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵學(xué)術(shù)創(chuàng)新。2021年影響因子為12.02，
| 大類學(xué)科 | 分區(qū) | 小類學(xué)科 | 分區(qū) | Top期刊 | 綜述期刊 |
| 醫(yī)學(xué) | 1區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 2區(qū) 2區(qū) | 是 | 否 |
| JCR分區(qū)等級 | JCR所屬學(xué)科 | 分區(qū) | 影響因子 |
| Q1 | IMMUNOLOGY | Q1 | 12.02 |
| ONCOLOGY | Q1 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 12.02 | 62 | 1.69% | 96.40% | 未開放 | -- |
課題、SCI/EI/SSCI怎么寫？